HSR21-051: Treatment Outcomes Among HR+/HER2- Advanced/Metastatic Breast Cancer Patients Receiving CDK 4 & 6 Inhibitors in a United States Clinical Practice Setting

2021 ◽  
Vol 19 (3.5) ◽  
pp. HSR21-051
Author(s):  
Yu-Jing Huang ◽  
Paula D. Ryan ◽  
Gregory L. Price ◽  
Gebra Cuyun Carter ◽  
Kristin M. Sheffield ◽  
...  
2018 ◽  
Vol 36 (15_suppl) ◽  
pp. e18617-e18617
Author(s):  
Adriana Reis Brandao Matutino ◽  
Allan Andresson Lima Pereira ◽  
Elizabeth Kornaga ◽  
Sasha M. Lupichuk ◽  
Sunil Verma

Sign in / Sign up

Export Citation Format

Share Document